You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 137 No. 6, June 1977 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Platelet-Inhibiting Drugs in Thrombotic Thrombocytopenic Purpura

Robert H. Eckel, MD; Edward B. Crowell, Jr, MD; Blake E. Waterhouse, MD; Marek J. Bozdech, MD

Arch Intern Med. 1977;137(6):735-737.


Abstract



Two patients with thrombotic thrombocytopenic purpura were seen. Aspirin, dipyridamole, and sulfinpyrazone were administered to patient 1 after splenectomy, and administration of high-dose prednisone and methylprednisolone failed to induce remission. The platelet count rose, but the patient had a relapse when the dipyridamole dose was tapered. This condition responded to an increase of the drug, and the patient obtained a long-lasting remission. A splenectomy was not performed on patient 2, and all three platelet-inhibiting drugs, together with prednisone, were given. This resulted in a prompt remission that has been sustained for 29 weeks. Morphologic changes in the peripheral blood smear remained for several weeks after other features of the disease had resolved. Thus, in both cases, platelet-inhibiting drugs appeared to induce a remission.

(Arch Intern Med 113:735-737, 1977)



Author Affiliations



From the Department of Medicine, University of Wisconsin, and Methodist Hospitals, Madison, Wis. Dr Eckel is now with the Department of Medicine, University of Washington, Seattle; Dr Crowell is now with Christian Medical College, Ludhiana, Punjab, India; Dr Bozdech is now with the Department of Medicine, University of California at San Francisco.


Footnotes



Accepted for publication July 13, 1976.

Reprint requests to Department of Medicine, University of Washington, Mail Stop RG-20, 1959 NE Pacific, Seattle, WA 98195 (Dr Eckel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thrombotic Thrombocytopenic Purpura: A Reappraisal
Crain and Choudhury
JAMA 1981;246:1243-1246.
ABSTRACT  

Plasma Infusion for Thrombotic Thrombocytopenic Purpura During Pregnancy
Walker et al.
Arch Intern Med 1980;140:981-983.
ABSTRACT  

Primary Hemochromatosis With Hereditary Spherocytosis
Zimelman and Miller
Arch Intern Med 1980;140:983-984.
ABSTRACT  

Thrombotic Thrombocytopenic Purpura: Combined Treatment with Plasmapheresis and Antiplatelet Agents
MYERS et al.
ANN INTERN MED 1980;92:149-155.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.